SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000312069-23-000034
Filing Date
2023-01-30
Accepted
2023-01-30 15:06:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 TBPHSC13G0223.txt SC 13G 13958
  Complete submission text file 0000312069-23-000034.txt   15743
Mailing Address 1 CHURCHILL PLACE CANARY WHARF LONDON X0 E14 5HP
Business Address 1 CHURCHILL PLACE CANARY WHARF LONDON X0 E14 5HP 00442031340952
BARCLAYS PLC (Filed by) CIK: 0000312069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6029 Commercial Banks, NEC

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 23567192
SIC: 2834 Pharmaceutical Preparations